Paloma Partners Management Co - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Paloma Partners Management Co ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2020$44,000
-75.8%
17,447
-58.9%
0.00%
-75.0%
Q3 2019$182,000
+167.6%
42,500
+232.7%
0.00%
+300.0%
Q4 2016$68,000
-69.8%
12,776
-68.1%
0.00%
-66.7%
Q3 2016$225,000
+287.9%
40,000
+277.2%
0.00%
+200.0%
Q2 2016$58,000
-47.3%
10,605
-61.3%
0.00%
-80.0%
Q2 2014$110,000
+266.7%
27,372
+93.2%
0.01%
+150.0%
Q2 2013$30,00014,1650.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders